• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Acute Erythroid Leukemia

Acute Erythroid Leukemia - 171 Studies Found

Active, not recruiting : Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission
: Leukemia
: 2007-09-20
:
  • Biological: aldesleukin
  • Biological: filgra

Completed : Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
: Leukemia
: 2007-09-10
:
  • Drug: cytarabine Other Names:

Active, not recruiting : Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
: Leukemia
: 2007-07-30
:
  • Drug: imatinib mesylate Patien

Completed : Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
:
  • Leukemia
  • Myelodysplastic Syndromes

: 2007-03-27
:
  • Biological: alemtuzumab
  • Drug: arsenic trio

Completed : Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
: Leukemia
: 2007-03-27
:
  • Biological: PR1 leukemia peptide vaccine

Active, not recruiting : Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
:
  • Leukemia
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myelopr
    : 2007-01-19
    :
    • Biological: sargramostim
    • Drug: bexarotene

Completed : Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
: Leukemia
: 2006-02-23
:
  • Drug: clofarabine
  • Drug: cytarabine

Terminated : Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia
: Leukemia
: 2005-12-20
:
  • Drug: Gemcitabine Hydrochloride

Completed : Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
: Leukemia
: 2005-12-20
:
  • Drug: cytarabine 300 mg/m2/day

Completed : Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
: Leukemia
: 2005-11-22
:
  • Biological: filgrastim
  • Drug: cladribine

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.